Olive Tree Capital
Description
Olive Tree Capital, based in Boston, Massachusetts, is an investment firm primarily focused on deploying capital across various asset classes, with a significant emphasis on private growth equity. The firm targets disruptive technology companies that exhibit strong management teams and possess proven business models. Its strategic approach involves identifying innovative ventures poised for substantial scaling and market impact.
The firm typically engages with companies in their growth phases, specifically participating in Series A, B, and C funding rounds. Olive Tree Capital's initial investment size for these rounds ranges from a minimum of $5 million to a maximum of $25 million, demonstrating their commitment to providing substantial capital for expansion. Beyond initial investments, the firm also actively participates in follow-on rounds, supporting their portfolio companies through subsequent growth milestones and capital needs.
Olive Tree Capital maintains a diversified sector focus within technology, including but not limited to Software-as-a-Service (SaaS), FinTech, Healthcare IT, and E-commerce. Their portfolio showcases a track record of backing companies that have achieved significant milestones, including successful public market exits via IPOs, such as Xometry, Root Insurance, and Toast. This strategic focus on high-growth sectors and robust exit potential underscores their disciplined investment philosophy aimed at generating strong returns for their limited partners.
Investor Profile
Olive Tree Capital has backed more than 49 startups, with 5 new investments in the last 12 months alone. The firm has led 5 rounds, about 10% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, India, United Arab Emirates.
- Strong thematic focus on FinTech, Health Care, Financial Services.
- Typical check size: $5M – $25M.
Stage Focus
- Seed (47%)
- Series A (18%)
- Series C (10%)
- Series B (8%)
- Series D (6%)
- Series Unknown (4%)
- Pre Seed (4%)
- Undisclosed (2%)
Country Focus
- United States (63%)
- India (14%)
- United Arab Emirates (6%)
- Nigeria (4%)
- Canada (4%)
- Switzerland (2%)
- Chile (2%)
- Israel (2%)
- Mexico (2%)
Industry Focus
- Fintech
- Health Care
- Financial Services
- Software
- Artificial Intelligence (Ai)
- Medical
- Biotechnology
- Therapeutics
- Payments
- Wellness
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.